Angiotensin Production by the Heart

Author:

van Kats Jorge P.1,Danser A. H. Jan1,van Meegen Jan R.1,Sassen Loes M. A.1,Verdouw Pieter D.1,Schalekamp Maarten A. D. H.1

Affiliation:

1. From the Departments of Internal Medicine (J.P.v.K., M.A.D.H.S.), Experimental Cardiology (J.P.v.K., J.R.v.M., L.M.A.S., P.D.V.), and Pharmacology (A.H.J.D.), Cardiovascular Research Institute Erasmus University Rotterdam (COEUR), the Netherlands.

Abstract

Background —Beneficial effects of ACE inhibitors on the heart may be mediated by decreased cardiac angiotensin II (Ang II) production. Methods and Results —To determine whether cardiac Ang I and Ang II are produced in situ or derived from the circulation, we infused 125 I-labeled Ang I or II into pigs (25 to 30 kg) and measured 125 I-Ang I and II as well as endogenous Ang I and II in cardiac tissue and blood plasma. In untreated pigs, the tissue Ang II concentration (per gram wet weight) in different parts of the heart was 5 times the concentration (per milliliter) in plasma, and the tissue Ang I concentration was 75% of the plasma Ang I concentration. Tissue 125 I-Ang II during 125 I-Ang II infusion was 75% of 125 I-Ang II in arterial plasma, whereas tissue 125 I-Ang I during 125 I-Ang I infusion was <4% of 125 I-Ang I in arterial plasma. After treatment with the ACE inhibitor captopril (25 mg twice daily), Ang II fell in plasma but not in tissue, and Ang I and renin rose both in plasma and tissue, whereas angiotensinogen did not change in plasma and fell in tissue. Tissue 125 I-Ang II derived by conversion from arterially delivered 125 I-Ang I fell from 23% to <2% of 125 I-Ang I in arterial plasma. Conclusions —Most of the cardiac Ang II appears to be produced at tissue sites by conversion of in situ–synthesized rather than blood-derived Ang I. Our study also indicates that under certain experimental conditions, the heart can maintain its Ang II production, whereas the production of circulating Ang II is effectively suppressed.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Cited by 169 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3